Victor Casanova
Antiviral therapeutic approaches for human rhinovirus infections
Casanova, Victor; Sousa, Filipa H; Stevens, Craig; Barlow, Peter G
Authors
Filipa H Sousa
Dr Craig Stevens C.Stevens@napier.ac.uk
Associate Professor
Prof Peter Barlow P.Barlow@napier.ac.uk
Professor
Abstract
Human rhinoviruses (RV) are the primary etiological agent of the common cold. This infection can be mild and self-limiting in immunocompetent hosts, but can be associated with bronchiolitis in infants, pneumonia in the immunosuppressed, and exacerbations of pre-existing pulmonary conditions such as asthma or chronic obstructive pulmonary disease. Many of these conditions can place significant economic costs upon healthcare infrastructure. There is currently no licenced vaccine for rhinovirus, as the large variety of RV serotypes has posed significant challenges for research. In this review we discuss current knowledge around antiviral drugs and small molecule inhibitors of rhinovirus infection, as well as antiviral host defence peptides as exciting prospects to approach the development of novel therapeutics which target human rhinovirus.
Citation
Casanova, V., Sousa, F. H., Stevens, C., & Barlow, P. G. (2018). Antiviral therapeutic approaches for human rhinovirus infections. Future Virology, https://doi.org/10.2217/fvl-2018-0016
Journal Article Type | Review |
---|---|
Acceptance Date | Apr 20, 2018 |
Online Publication Date | Jun 12, 2018 |
Publication Date | Jun 12, 2018 |
Deposit Date | May 17, 2018 |
Publicly Available Date | May 17, 2018 |
Journal | Future Virology |
Print ISSN | 1746-0794 |
Electronic ISSN | 1746-0808 |
Publisher | Future Medicine |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.2217/fvl-2018-0016 |
Keywords | rhinovirus, peptide, antiviral drugs, cathelicidin, interferon, vitamin D |
Public URL | http://researchrepository.napier.ac.uk/Output/1185214 |
Contract Date | May 17, 2018 |
Files
Antiviral therapeutic approaches for human rhinovirus infections
(1.4 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Inflammatory Bowel Disease Drugs: A Focus on Autophagy
(2016)
Journal Article
The Role of Autophagy in Crohn’s Disease
(2012)
Journal Article
Autophagy: from basic science to clinical application
(2009)
Journal Article
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search